The largest U.S. pharmacy benefit manager, Express Scripts, is cutting back on compounded medications, saying most are ineffective or overpriced.» Read More
Some of Thursday's midday movers:
April 17- UnitedHealth Group Inc, the largest U.S. health insurer, said on Thursday it has spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc, a higher cost than it expected by "multiples," sending shares in the sector lower.
Does your portfolio leave you feeling a little nauseous? Cramer thinks shares of Aetna could make you feel a lot better.
March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 8 percent, Amgen Inc dropped 3 percent and Celgene Corp lost 3.7 percent.
March 21- U.S. lawmakers have asked Gilead Sciences Inc to explain the $84,000 price tag of its new hepatitis C drug Sovaldi, which is encountering resistance from health insurers and state Medicaid programs. Biogen Idec fell 6 percent, Amgen Inc dropped 2.5 percent and Celgene Corp was down 2 percent.
*Nike falls after results, Tiffany rises. Geopolitical issues remained in focus after President Vladimir Putin signed laws completing Russia's annexation of Crimea and investors took fright at a U.S. decision to slap sanctions on his inner circle.
*Nike shares fall in premarket after outlook. NEW YORK, March 21- U.S. stock index futures pointed to a slightly higher open on Friday, with major indexes on track for a week of strong gains, though geopolitical concerns remained in view as the tenuous situation in Ukraine continued.
*Nike shares fall in premarket after outlook. NEW YORK, March 21- U.S. stock index futures edged higher on Friday, with major indexes on track for a week of strong gains, though geopolitical concerns remained in view as the tenuous situation in Ukraine continued.
Some of the names on the move ahead of the open.
As Americans rush to sign up for Obamacare plans before the March 31 deadline, investors have turned bullish on health insurers.
NEW YORK, March 6- Shopping for employee health insurance on private marketplaces might be the way of the future for tens of millions. However, expert opinions about growth have been based on projections, not actual consumer behavior in the exchanges that only really got going last year.
Several insurers, including Molina Healthcare, which administer health plans for California's Medicaid program for the poor are asking states to step in and pay for Gilead Sciences Inc's Sovaldi, a drug that costs $84,000 per patient.
With stocks near all-time highs, short interest reached the highest level in 20 months, but some investors are seeing the trend as a bullish sign.
Some of Monday's midday movers:
Humana shares surged more than 7 percent Monday after it said proposed health department rate cuts may be more benign than anticipated.
Feb 7- Cigna Corp on Friday said costs in its private Medicare business were higher than expected in the fourth quarter and might continue on that path in 2014, resulting in a disappointing outlook and pushing its shares down nearly 9 percent.
Feb 6- Aetna Inc, the third-largest U.S. health insurer, said on Thursday it expects to lose money on the Obamacare exchanges even as demand for these insurance plans has picked up over the past few weeks.
Feb 6- Aetna Inc, the third-largest U.S. health insurer, said on Thursday that demand for insurance plans on the Obamacare exchanges had picked up in the last few weeks and that it had signed up 135,000 paid members through the end of January.
Feb 5- Humana Inc said on Wednesday that it received 202,000 applications for Obamacare health insurance plans, many of them from young people, but still gave a wide forecast for 2014 profit as it waits to see the demographics of future customers.
Feb 5- U.S. health insurer Humana Inc said on Wednesday that it had received 202,000 applications through Jan. 31 for 2014 Obamacare health insurance plans in the 14 states where it offers them.